Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aramis Pharmed is a private pharmaceutical company headquartered in Tehran, Iran, dedicated to the development and manufacturing of high-quality generic pharmaceutical products. The company maintains a significant focus on oncology, producing essential treatments such as imatinib, sunitinib, and sorafenib to improve patient access to cancer care. Beyond oncology, Aramis Pharmed's portfolio includes medications for cardiovascular, neurological, and gastrointestinal therapeutic areas. The company operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Aramis Pharmed aims to serve both the Iranian domestic market and export markets through strategic partnerships and a commitment to pharmaceutical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aramis Pharmed.